Associations Between Routine Laboratory Markers and FIB-4 in Adults with Diabetes: An Exploratory Cross-Sectional Study

Background/Objectives: Routine laboratory markers may characterise FIB-4 risk profiles in adults with diabetes. This study examined associations between FIB-4 and an exploratory composite of gamma-glutamyl transferase (GGT), neutrophil-to-lymphocyte ratio (NLR) and red cell distribution width (RDW), termed GNR-3, and assessed whether the composite provided measurable discrimination beyond GGT alone. Methods: A cross-sectional secondary analysis included 60 adults with documented diabetes and prospectively collected baseline data. FIB-4 and GNR-3 were recalculated from the supplied anonymised records. Analyses included rank correlations, covariate-adjusted associations, false-discovery-rate adjustment and paired receiver operating characteristic comparisons. Confidence intervals were estimated using 20,000 participant-level bootstrap samples. The binary discrimination endpoint was high FIB-4 (>2.67), not a confirmed diagnosis of liver fibrosis. Results: Low, intermediate and high FIB-4 classifications occurred in 9, 36 and 15 participants, respectively. GNR-3 correlated with FIB-4 (ρ = 0.364, 95% confidence interval [CI] 0.093–0.596) and retained an association after adjustment for age and sex (partial ρ = 0.351, q = 0.0274). Apparent areas under the receiver operating characteristic curve for high FIB-4 were 0.811 for GNR-3 and 0.753 for GGT. Their paired difference was 0.058 (95% CI −0.048 to 0.166, DeLong p = 0.275), providing no evidence that the composite discriminated high FIB-4 better than GGT alone. Age-adapted classification reclassified nine participants without changing the high category. Conclusions: GNR-3 was associated with FIB-4 in this small exploratory cohort, but its apparent discrimination of high FIB-4 did not demonstrate an advantage over GGT alone. These findings concern FIB-4 risk classification rather than diagnosis of liver fibrosis and do not support clinical use of the composite. Independent evaluation using clinically characterised liver outcomes would be required before considering further application.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-16
DOI
https://doi.org/10.3390/diagnostics16223801
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Associations Between Routine Laboratory Markers and FIB-4 in Adults with Diabetes: An Exploratory Cross-Sectional Study

Rodica Pădureanu, Virginia Maria Rădulescu, Ion Rogoveanu, Simona Bănicioiu-Covei et al.
3 links
Diagnostics
Liver Disease Diagnosis and Treatment
article

Associations Between Routine Laboratory Markers and FIB-4 in Adults with Diabetes: An Exploratory Cross-Sectional Study

Rodica Pădureanu, Virginia Maria Rădulescu, Ion Rogoveanu, Simona Bănicioiu-Covei, Vlad Pădureanu, Cristin-Constantin Vere, Diana-Rodica Tudorașcu
article en

Abstract

Background/Objectives: Routine laboratory markers may characterise FIB-4 risk profiles in adults with diabetes. This study examined associations between FIB-4 and an exploratory composite of gamma-glutamyl transferase (GGT), neutrophil-to-lymphocyte ratio (NLR) and red cell distribution width (RDW), termed GNR-3, and assessed whether the composite provided measurable discrimination beyond GGT alone. Methods: A cross-sectional secondary analysis included 60 adults with documented diabetes and prospectively collected baseline data. FIB-4 and GNR-3 were recalculated from the supplied anonymised records. Analyses included rank correlations, covariate-adjusted associations, false-discovery-rate adjustment and paired receiver operating characteristic comparisons. Confidence intervals were estimated using 20,000 participant-level bootstrap samples. The binary discrimination endpoint was high FIB-4 (>2.67), not a confirmed diagnosis of liver fibrosis. Results: Low, intermediate and high FIB-4 classifications occurred in 9, 36 and 15 participants, respectively. GNR-3 correlated with FIB-4 (ρ = 0.364, 95% confidence interval [CI] 0.093–0.596) and retained an association after adjustment for age and sex (partial ρ = 0.351, q = 0.0274). Apparent areas under the receiver operating characteristic curve for high FIB-4 were 0.811 for GNR-3 and 0.753 for GGT. Their paired difference was 0.058 (95% CI −0.048 to 0.166, DeLong p = 0.275), providing no evidence that the composite discriminated high FIB-4 better than GGT alone. Age-adapted classification reclassified nine participants without changing the high category. Conclusions: GNR-3 was associated with FIB-4 in this small exploratory cohort, but its apparent discrimination of high FIB-4 did not demonstrate an advantage over GGT alone. These findings concern FIB-4 risk classification rather than diagnosis of liver fibrosis and do not support clinical use of the composite. Independent evaluation using clinically characterised liver outcomes would be required before considering further application.

DiagnosticsVol. 16(22)
University of Medicine and Pharmacy of Craiova (RO), University of Craiova (RO)
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon